Free Twice-Weekly Pharma Manufacturing Newsletter Stay current on Biopharma Packing & Security, Supply Chain Software & Systems, and Contract Manufacturing with a twice-weekly update sent straight to your Inbox. Join more than 30,000 pharma professionals who subscribe to FiercePharmaManufacturing for FREE!
The Boston Globe has taken a detailed look at the catalog of decisions that let to the fungal meningitis outbreak earlier this year. And the piece sheds some light on how compounding pharmacies stepped in to fill gaps left by shortages of drugs from manufacturers. "[Hospitals] were freaking out. If they couldn't get these drugs, patients were going to die," an anonymous former New England Compounding Center salesman said. Article
FiercePharma's Carly Helfand and FierceBiotech's Damian Garde discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a consideration of how a certain biotech entrepreneur is bringing attention to an FDA loophole.
FiercePharmaManufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Click here to get your free twice weekly email briefing today!